2017 Global Pneumococcal Vaccine Industry Research Report

The report provides a comprehensive analysis of the Pneumococcal Vaccine industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Pneumococcal Vaccine industry in USA, EU, China,India, Japan and other regions, and forecast to 2022, from 2017.

Market Analysis by Players:
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac

Market Analysis by Regions:
North America
Europe
China
Japan
Others

Market Analysis by Types:
PPSV 23
PCV 7/13
PCV 10

Market Analysis by Applications:
For Infants
For Children (2-10)
For Person (10-64)
For The Old (≥65)

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports